Table 2 Limitations of peptide vaccines

• Unique individual tumor-specific antigens difficult to include.

• Rapid degradation in vivo.

• Heterogeneity of tumor antigen expression.

• Ignorance. We don't yet know how best to vaccinate with them. *

• Clinical responses have been rare in most series (with peptide or any vaccine alone).*